BackAvineuro Pharmaceuticals, Inc. A Global Neuroscience Research And Development Company Developing novel small molecules to treat unmet medical needs in the neurological and psychiatric fields.
San Diego, CA – October 28th, 2008.
Avineuro Pharmaceuticals, Inc was founded in August 2008 and is headquartered in San Diego, CA. The company operates in a virtual mode through outsourcing of the discovery, development and clinical activities. Avineuro’s pipeline consists of pre-clinical drug candidates for treatment of Alzheimer’s Disease, anxiety, depression, schizophrenia and obesity. In September 2008, Avineuro entered into an exclusive licensing agreement with ChemDiv Inc. for drug candidates for treatment of multiple neurological and psychiatric indications. These candidates were identified from ChemDiv’s discovery platform through screening of its proprietary chemical library against a panel of GPCRs implicated in the pathophysiology of Alzheimer disease.
Contact:
Yan Lavrovsky, CEO
Avineuro Pharmaceuticals, Inc.
6605 Nancy Ridge Drive, Suite 126
San Diego, CA 92121
Tel 858-436-1537 / 858-436-1540
Fax 858-228-9798
Email: YLavrovsky@avineuro.com